Abstract
The stubbornly high incidence of new HIV infections belies the overwhelming evidence showing that sustained highly active antiretroviral therapy (HAART) has the power to dramatically reduce the spread of HIV infection and forever change the face of this devastating epidemic. One of the main contributors to this public health paradox is the ongoing HIV epidemic among substance users who contribute significantly to HIV infection rates through injection drug use and high-risk sexual behaviours. Current evidence clearly shows that, in order to fill this gap, we need to integrate substance abuse treatment with HIV treatment programmes and provide substance abusers with universal access to HIV treatment through a focussed effort to seek, test, treat, and retain hard-to-reach high risk individuals. These aims will require structural changes in the health care system to overcome many of the obstacles that have inhibited the merging of substance abuse treatment with HIV programmes for far too long.
Keywords: HAART, highly active antiretroviral therapy, HIV prevention, substance use disorders, treatment, opioid addiction, Disease Control and Prevention, opiate replacement therapy, hypothesis
Current HIV Research
Title: The Unrealized Potential of Addiction Science in Curbing the HIV Epidemic
Volume: 9 Issue: 6
Author(s): Nora D. Volkow, Ruben D. Baler and Jacques L. Normand
Affiliation:
Keywords: HAART, highly active antiretroviral therapy, HIV prevention, substance use disorders, treatment, opioid addiction, Disease Control and Prevention, opiate replacement therapy, hypothesis
Abstract: The stubbornly high incidence of new HIV infections belies the overwhelming evidence showing that sustained highly active antiretroviral therapy (HAART) has the power to dramatically reduce the spread of HIV infection and forever change the face of this devastating epidemic. One of the main contributors to this public health paradox is the ongoing HIV epidemic among substance users who contribute significantly to HIV infection rates through injection drug use and high-risk sexual behaviours. Current evidence clearly shows that, in order to fill this gap, we need to integrate substance abuse treatment with HIV treatment programmes and provide substance abusers with universal access to HIV treatment through a focussed effort to seek, test, treat, and retain hard-to-reach high risk individuals. These aims will require structural changes in the health care system to overcome many of the obstacles that have inhibited the merging of substance abuse treatment with HIV programmes for far too long.
Export Options
About this article
Cite this article as:
D. Volkow Nora, D. Baler Ruben and L. Normand Jacques, The Unrealized Potential of Addiction Science in Curbing the HIV Epidemic, Current HIV Research 2011; 9 (6) . https://dx.doi.org/10.2174/157016211798038605
DOI https://dx.doi.org/10.2174/157016211798038605 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Resolvins: Endogenously-Generated Potent Painkilling Substances and their Therapeutic Perspectives
Current Neuropharmacology Hippocampal-Dependent Inhibitory Learning and Memory Processes in the Control of Eating and Drug Taking
Current Pharmaceutical Design Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
Current Pharmaceutical Design Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Formulation Development and Characterization of Controlled Release Core-in-cup Matrix Tablets of Venlafaxine HCl
Current Drug Therapy Anti-Inflammatory Treatments for Chronic Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology Botulinum Toxin: A Successful Therapeutic Protein
Current Medicinal Chemistry Skin Manifestations in Course of Celiac Disease: Case Report and Review of the Literature
Current Pharmaceutical Design Patent Selections:
Recent Patents on Chemical Engineering Strategies for Targeting Lentiviral Vectors
Current Gene Therapy Identification of Nuclear Proteins in Soybean Under Flooding Stress using Proteomic Technique
Protein & Peptide Letters Changes in Cognition, Depression and Quality of Life after Carotid Stenosis Treatment
Current Neurovascular Research Human Disease and Drug Pharmacology, Complex as Real Life
Current Medicinal Chemistry Side Effects of Atypical Antipsychotic Drugs
Current Pharmaceutical Design The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review
Current HIV Research Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Aging Property of G2013 Molecule as a Novel Immunosuppressive Agent on Enzymatic and Non-Enzymatic Oxidative Stress Determinants in Rat Model
Current Drug Discovery Technologies